Top

European Journal of Nutrition

Published in:

01-02-2022 | Ulcerative Colitis | Review

Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic review and meta-analysis

Authors: Yuanyuan Guan, Yang Hao, Yun Guan, Huaien Bu, Hongwu Wang

Published in: European Journal of Nutrition | Issue 1/2022

Abstract

Objective

Observational studies have shown that vitamin D levels are inversely related to ulcerative colitis activity, yet evidence from population interventions remains inconsistent. We conducted a systematic review and meta-analysis of randomized-controlled trials to clarify the effect of vitamin D on blood markers in patients with ulcerative colitis.

Methods

The PubMed, Cochrane Library, Embase, CNKI, VIP, and Wanfang databases were searched for studies published before June 2020. Information was collected regarding serum vitamin D levels, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP), and Ca (calcium), and parathyroid hormone (PTH), and ulcerative colitis disease activity index (UCDAI) research data.

Results

Seven studies (n = 539) were included in the meta-analysis. Vitamin D supplementation resulted in significant improvements in the serum vitamin D levels (standardized mean difference (SMD) = 0.69, 95% CI (0.36, 1.03), P < 0.001), ESR (weighted mean difference (WMD) = − 1.10, 95% CI (− 1.97, − 0.24), P = 0.01), CRP (SMD = − 0.43, 95% CI (− 0.67, − 0.20), P = 0.0003), and Ca (SMD = 0.92, 95% CI (0.09, 1.74), P = 0.03) but not in other outcomes. According to subgroup analysis, supplementation with vitamin D at a dose of ≥ 300,000 IU/day can improve serum vitamin D levels. Supplementation with a sufficient dose of vitamin D in a short period of time can also improve serum vitamin D levels. According to GRADE method evaluation, the evidence quality was classified as low for the Serum Vitamin D Level and ESR, and very low for the CRP, PTH, Ca, and UCDAI.

Conclusions

Compared with placebo control interventions, vitamin D supplementation seemed to be an effective intervention for patients with ulcerative colitis. Different doses of vitamin D and durations of intervention produce different effects. However, due to the limitation of the quality of the included studies, the above conclusions still need to be verified by more high-quality studies and weak clinical recommendations.

Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347(6):417–429. https://doi.org/10.1056/NEJMra020831CrossRefPubMed

Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, Kato J, Kobayashi K, Kobayashi K, Koganei K, Kunisaki R, Motoya S, Nagahori M, Nakase H, Omata F, Saruta M, Watanabe T, Tanaka T, Kanai T, Noguchi Y, Takahashi KI, Watanabe K, Hibi T, Suzuki Y, Watanabe M, Sugano K, Shimosegawa T (2018) Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol 53(3):305–353. https://doi.org/10.1007/s00535-018-1439-1CrossRefPubMedPubMedCentral

Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017) Ulcerative colitis. Lancet 389(10080):1756–1770. https://doi.org/10.1016/s0140-6736(16)32126-2CrossRefPubMed

Foppen MHG, Rozeman EA, van Wilpe S, Postma C, Snaebjornsson P, van Thienen JV, van Leerdam ME, van den Heuvel M, Blank CU, van Dieren J, Haanen J (2018) Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management. Esmo Open. https://doi.org/10.1136/esmoopen-2017-000278CrossRef

Lopez-Siles M, Enrich-Capo N, Aldeguer X, Sabat-Mir M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M (2018) Alterations in the abundance and co-occurrence of akkermansia muciniphila and faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects. Front Cell Infect Microbiol 8:16. https://doi.org/10.3389/fcimb.2018.00281CrossRef

Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390(10114):2769–2778. https://doi.org/10.1016/s0140-6736(17)32448-0CrossRefPubMed

Olén O, Erichsen R, Sachs MC, Pedersen L, Halfvarson J, Askling J, Ekbom A, Sørensen HT, Ludvigsson JF (2020) Colorectal cancer in ulcerative colitis: a scandinavian population-based cohort study. Lancet 395(10218):123–131. https://doi.org/10.1016/s0140-6736(19)32545-0CrossRefPubMed

Garland CF, Kim JJ, Mohr SB, Gorham ED, Grant WB, Giovannucci EL, Baggerly L, Hofflich H, Ramsdell JW, Zeng K, Heaney RP (2014) Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health 104(8):e43-50. https://doi.org/10.2105/ajph.2014.302034CrossRefPubMedPubMedCentral

Hossein-nezhad A, Holick MF (2013) Vitamin D for health: a global perspective. Mayo Clin Proc 88(7):720–755. https://doi.org/10.1016/j.mayocp.2013.05.011CrossRefPubMed

10.

Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ, Kienreich K, Soni M (2013) Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—a review of recent evidence. Autoimmun Rev 12(10):976–989. https://doi.org/10.1016/j.autrev.2013.02.004CrossRefPubMed

11.

Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, Bischoff-Ferrari HA, Cavalier E, Ebeling PR, Fardellone P, Gandini S, Gruson D, Guérin AP, Heickendorff L, Hollis BW, Ish-Shalom S, Jean G, von Landenberg P, Largura A, Olsson T, Pierrot-Deseilligny C, Pilz S, Tincani A, Valcour A, Zittermann A (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9(11):709–715. https://doi.org/10.1016/j.autrev.2010.06.009CrossRefPubMed

12.

Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, Povoroznyuk V, Balatska N, Barbosa AP, Karonova T, Rudenka E, Misiorowski W, Zakharova I, Rudenka A, Łukaszkiewicz J, Marcinowska-Suchowierska E, Łaszcz N, Abramowicz P, Bhattoa HP, Wimalawansa SJ (2018) Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol 175:125–135. https://doi.org/10.1016/j.jsbmb.2017.01.021CrossRefPubMed

13.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930. https://doi.org/10.1210/jc.2011-0385CrossRef

14.

Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, Pierroz DD, Weber P, Hoffmann K (2014) A systematic review of vitamin D status in populations worldwide. Br J Nutr 111(1):23–45. https://doi.org/10.1017/s0007114513001840CrossRefPubMed

15.

Zhang Y, Fang F, Tang J, Jia L, Feng Y, Xu P, Faramand A (2019) Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ (Clin Res ed) 366:l4673. https://doi.org/10.1136/bmj.l4673CrossRef

16.

Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G (2016) Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 96(1):365–408. https://doi.org/10.1152/physrev.00014.2015CrossRefPubMed

17.

Nagpal S, Na S, Rathnachalam R (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26(5):662–687. https://doi.org/10.1210/er.2004-0002CrossRefPubMed

18.

Kamen DL, Tangpricha V (2010) Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl) 88(5):441–450. https://doi.org/10.1007/s00109-010-0590-9CrossRef

19.

Sarkar S, Hewison M, Studzinski GP, Li YC, Kalia V (2016) Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer. Crit Rev Clin Lab Sci 53(2):132–145. https://doi.org/10.3109/10408363.2015.1094443CrossRefPubMed

20.

Sassi F, Tamone C, D’Amelio P (2018) Vitamin D: nutrient, hormone, and immunomodulator. Nutrients. https://doi.org/10.3390/nu10111656CrossRefPubMedPubMedCentral

21.

Colotta F, Jansson B, Bonelli F (2017) Modulation of inflammatory and immune responses by vitamin D. J Autoimmun 85:78–97. https://doi.org/10.1016/j.jaut.2017.07.007CrossRefPubMed

22.

Bishop E, Ismailova A, Dimeloe SK, Hewison M, White JH (2020) Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR plus. https://doi.org/10.1002/jbm4.10405CrossRefPubMedPubMedCentral

23.

Vrablicova Z, Soltys K, Krajcovicova A, Sturdik I, Koller T, Huorka M, Payer J, Stuchlik S, Killinger Z, Jackuliak P, Stuchlikova M, Drahovska H, Hlavaty T (2018) Influence of vitamin D on the expression of mRNA of cytokines in the mucosa of inflammatory bowel disease patients. Bratisl Lek Listy 119(7):408–415. https://doi.org/10.4149/bll_2018_074CrossRefPubMed

24.

Cantorna MT (2016) IBD: Vitamin D and IBD: moving towards clinical trials. Nat Rev Gastroenterol Hepatol 13(6):322–323. https://doi.org/10.1038/nrgastro.2016.72CrossRefPubMed

25.

Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (London, England) 8(5):336–341. https://doi.org/10.1016/j.ijsu.2010.02.007CrossRef

26.

Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clin Res ed ) 336(7650):924–926. https://doi.org/10.1136/bmj.39489.470347.ADCrossRef

27.

Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135. https://doi.org/10.1186/1471-2288-14-135CrossRefPubMedPubMedCentral

28.

Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13. https://doi.org/10.1186/1471-2288-5-13CrossRefPubMedPubMedCentral

29.

Sharifi A, Vahedi H, Nedjat S, Mohamadkhani A, Hosseinzadeh Attar MJ (2019) Vitamin D decreases beck depression inventory score in patients with mild to moderate ulcerative colitis: a double-blind randomized placebo-controlled trial. J diet Suppl 16(5):541–549. https://doi.org/10.1080/19390211.2018.1472168CrossRefPubMed

30.

Sharifi A, Vahedi H, Nedjat S, Rafiei H, Hosseinzadeh-Attar MJ (2019) Effect of single-dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo-controlled trial. APMIS Acta Pathol Microbiol et Immunol Scand 127(10):681–687. https://doi.org/10.1111/apm.12982CrossRef

31.

Tan B, Li P, Lv H, Yang H, Li Y, Li J, Wang O, Qian JM (2018) Treatment of vitamin D deficiency in Chinese inflammatory bowel disease patients: a prospective, randomized, open-label, pilot study. J Dig Dis 19(4):215–224. https://doi.org/10.1111/1751-2980.12590CrossRefPubMed

32.

Ahamed ZR, Dutta U, Sharma V, Prasad KK, Popli P, Kalsi D, Vaishnavi C, Arora S, Kochhar R (2019) Oral nano vitamin D supplementation reduces disease activity in ulcerative colitis: a double-blind randomized parallel group placebo-controlled trial. J Clin Gastroenterol 53(10):e409–e415. https://doi.org/10.1097/mcg.0000000000001233CrossRef

33.

Emami MR, Sharifi A, Yaseri M, Derakhshanian H, Hosseinzadeh-Attar MJ (2020) Vitamin D suppresses proangiogenic factors in patients with ulcerative colitis: a randomized double blind placebo controlled clinical trial. Complement Ther Clin Pract 39:101086. https://doi.org/10.1016/j.ctcp.2020.101086CrossRefPubMed

34.

Sharifi A, Vahedi H, Honarvar MR, Amiriani T, Nikniaz Z, Rad EY, Hosseinzadeh-Attar MJ (2020) Vitamin D decreases CD40L gene expression in ulcerative colitis patients: a randomized, double-blinded, placebo-controlled trial. Turk J Gastroenterol Off J Turk Soc Gastroenterol 31(2):99–104. https://doi.org/10.5152/tjg.2020.181028CrossRef

35.

Javad Hosseinzadeh-Attar M, Sharifi A, Nedjat S, Mohamadkhani A, Vahedi H (2020) The effect of vitamin D on serum asymmetric dimethylarginine in patients with mild to moderate ulcerative colitis. Int J Vitam Nutr Res Int Z fur Vitam und Ernahrungsforschung J Int de vitaminol et de nutr 90(1–2):17–22. https://doi.org/10.1024/0300-9831/a000303CrossRef

36.

Kimmel J, Axelrad J (2020) The complex interplay between inflammatory bowel disease and malignancy. Curr Gastroenterol Rep 22(3):13. https://doi.org/10.1007/s11894-020-0747-9CrossRefPubMed

37.

Yousaf A, Raiker R, Davis SM, Gayam S, Zinn Z (2020) Association between psoriasis, psoriatic arthritis and gastrointestinal disease : an exploratory nationwide inpatient sample analysis. Wien Klin Wochenschr. https://doi.org/10.1007/s00508-020-01740-8CrossRefPubMed

38.

Carreras-Torres R, Ibáñez-Sanz G, Obón-Santacana M, Duell EJ, Moreno V (2020) Identifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study. Sci Rep 10(1):19273. https://doi.org/10.1038/s41598-020-76361-2CrossRefPubMedPubMedCentral

39.

Kaenkumchorn T, Wahbeh G (2020) Ulcerative colitis: making the diagnosis. Gastroenterol Clin N Am 49(4):655–669. https://doi.org/10.1016/j.gtc.2020.07.001CrossRef

40.

Du LL, Ha C (2020) Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin N Am 49(4):643. https://doi.org/10.1016/j.gtc.2020.07.005CrossRef

41.

Reches L, Israeli E (2020) Disability among patients with inflammatory bowel diseases: a cross sectional study. Harefuah 159(11):815–819PubMed

42.

Veselov AV, Belousova EA, Bakulin IG, Uspenskiy YP, Dreval RO, Shkurko TV, Kashnikov BN, Fominykh YA, Knyazev OV, Romanov RI, Skalinskaia MI, Shipitsyn VV (2020) Economic burden and current status of the drug supply management for immune inflammatory diseases (by example of ulcerative colitis and crohn’s disease). Problemy sotsial’noi gigieny, zdravookhraneniia i istorii meditsiny 28(Special Issue):1137–1145. https://doi.org/10.32687/0869-866X-2020-28-s2-1137-1145CrossRefPubMed

43.

Rabbenou W, Ullman TA (2020) Risk of colon cancer and recommended surveillance strategies in patients with ulcerative colitis. Gastroenterol Clin N Am 49(4):791–807. https://doi.org/10.1016/j.gtc.2020.08.005CrossRef

44.

Carlberg C (2019) Nutrigenomics of vitamin D. Nutrients. https://doi.org/10.3390/nu11030676CrossRefPubMedPubMedCentral

45.

Mascitelli L, Goldstein MR, Pezzetta F (2010) Vitamin D deficiency and cardiovascular diseases. Recent Prog Med 101(5):202–211

46.

Karimi S, Tabataba-Vakili S, Ebrahimi-Daryani N, Yari Z, Karimi A, Hedayati M, Hekmatdoost A (2020) Inflammatory biomarkers response to two dosages of vitamin D supplementation in patients with ulcerative colitis: a randomized, double-blind, placebo-controlled pilot study. Clin Nutr ESPEN 36:76–81. https://doi.org/10.1016/j.clnesp.2020.02.003CrossRefPubMed

47.

Gubatan J, Chou ND, Nielsen OH, Moss AC (2019) Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease. Aliment Pharmacol Ther 50(11–12):1146–1158. https://doi.org/10.1111/apt.15506CrossRefPubMed

48.

Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68(Suppl 3):s1–s106. https://doi.org/10.1136/gutjnl-2019-318484CrossRefPubMed

49.

Carlsen K, Jakobsen C, Kallemose T, Paerregaard A, Riis LB, Munkholm P, Wewer V (2017) F-calprotectin and blood markers correlate to quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 65(5):539–545. https://doi.org/10.1097/mpg.0000000000001540CrossRefPubMed

50.

Muris AH, Smolders J, Rolf L, Thewissen M, Hupperts R, Damoiseaux J (2016) Immune regulatory effects of high dose vitamin D(3) supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study. J Neuroimmunol 300:47–56. https://doi.org/10.1016/j.jneuroim.2016.09.018CrossRefPubMed

51.

Qu R, Hu L, Ling Y, Hou Y, Fang H, Zhang H, Liang S, He Z, Fang M, Li J, Li X, Chen C (2020) C-reactive protein concentration as a risk predictor of mortality in intensive care unit: a multicenter, prospective, observational study. BMC Anesthesiol 20(1):292. https://doi.org/10.1186/s12871-020-01207-3CrossRefPubMedPubMedCentral

52.

Chen YH, Wang L, Feng SY, Cai WM, Chen XF, Huang ZM (2020) The relationship between c-reactive protein/albumin ratio and disease activity in patients with inflammatory bowel disease. Gastroenterol Res Pract. https://doi.org/10.1155/2020/3467419CrossRefPubMedPubMedCentral

53.

Tabatabaeizadeh SA, Avan A, Bahrami A, Khodashenas E, Esmaeili H, Ferns GA, Abdizadeh MF, Ghayour-Mobarhan M (2017) High dose supplementation of vitamin D affects measures of systemic inflammation: reductions in high sensitivity C-reactive protein level and neutrophil to lymphocyte ratio (NLR) distribution. J Cell Biochem 118(12):4317–4322. https://doi.org/10.1002/jcb.26084CrossRefPubMed

54.

Ikeuchi T, Nakamura T, Fukumoto S, Takada H (2013) A vitamin D3 analog augmented interleukin-8 production by human monocytic cells in response to various microbe-related synthetic ligands, especially NOD2 agonistic muramyldipeptide. Int Immunopharmacol 15(1):15–22. https://doi.org/10.1016/j.intimp.2012.10.027CrossRefPubMed

55.

Mandle HB, Jahan FA, Bostick RM, Baron JA, Barry EL, Yacoub R, Merrill J, Rutherford RE, Seabrook ME, Fedirko V (2019) Effects of supplemental calcium and vitamin D on tight-junction proteins and mucin-12 expression in the normal rectal mucosa of colorectal adenoma patients. Mol Carcinog 58(7):1279–1290. https://doi.org/10.1002/mc.23010CrossRefPubMedPubMedCentral

56.

Sylvester FA (2017) Inflammatory bowel disease: effects on bone and mechanisms. Adv Exp Med Biol 1033:133–150. https://doi.org/10.1007/978-3-319-66653-2_7CrossRefPubMed

57.

Almasmoum H, Refaat B, Ghaith MM, Almaimani RA, Idris S, Ahmad J, Abdelghany AH, BaSalamah MA, El-Boshy M (2019) Protective effect of Vitamin D3 against lead induced hepatotoxicity, oxidative stress, immunosuppressive and calcium homeostasis disorders in rat. Environ Toxicol Pharmacol 72:103246. https://doi.org/10.1016/j.etap.2019.103246CrossRefPubMed

58.

Garcia PM, Moore J, Kahan D, Hong MY (2020) Effects of vitamin D supplementation on inflammation, colonic cell kinetics, and microbiota in colitis: a review. Molecules (Basel, Switzerland). https://doi.org/10.3390/molecules25102300CrossRefPubMedCentral

59.

Dimitrov V, Barbier C, Ismailova A, Wang Y, Dmowski K, Salehi-Tabar R, Memari B, Groulx-Boivin E, White JH (2021) Vitamin D-regulated gene expression profiles: species-specificity and Cell-specific effects on metabolism and immunity. Endocrinology. https://doi.org/10.1210/endocr/bqaa218CrossRefPubMed

60.

Mousa A, Naderpoor N, Teede H, Scragg R, de Courten B (2018) Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 76(5):380–394. https://doi.org/10.1093/nutrit/nux077CrossRefPubMed

61.

Martin NG, Rigterink T, Adamji M, Wall CL, Day AS (2019) Single high-dose oral vitamin D3 treatment in New Zealand children with inflammatory bowel disease. Transl Pediatr 8(1):35–41. https://doi.org/10.21037/tp.2018.11.01CrossRefPubMedPubMedCentral

62.

Schoenmakers I, Ginty F, Jarjou LM, Nigdikar S, Bennett J, Laidlaw A, Prentice A (2010) Interrelation of parathyroid hormone and vitamin D metabolites in adolescents from the UK and The Gambia. J Steroid Biochem Mol Biol 121(1–2):217–220. https://doi.org/10.1016/j.jsbmb.2010.03.012CrossRefPubMed

63.

Gallagher JC, Jindal PS, Smith LM (2014) Vitamin D does not increase calcium absorption in young women: a randomized clinical trial. J Bone ad miner Res Off J Am Soc Bone Min Res 29(5):1081–1087. https://doi.org/10.1002/jbmr.2121CrossRef

64.

Macdonald HM, Reid IR, Gamble GD, Fraser WD, Tang JC, Wood AD (2018) 25-Hydroxyvitamin D threshold for the effects of vitamin D supplements on bone density: secondary analysis of a randomized controlled trial. J Bone Min Res Off J Am Soc Bone Min Res 33(8):1464–1469. https://doi.org/10.1002/jbmr.3442CrossRef

65.

Reid IR, Bolland MJ (2019) Controversies in medicine: the role of calcium and vitamin D supplements in adults. Med J Aust 211(10):468–473. https://doi.org/10.5694/mja2.50393CrossRefPubMed

Title: Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic review and meta-analysis
Authors: Yuanyuan Guan
Yang Hao
Yun Guan
Huaien Bu
Hongwu Wang
Publication date: 01-02-2022
Publisher: Springer Berlin Heidelberg
Keyword: Ulcerative Colitis
Published in: European Journal of Nutrition / Issue 1/2022
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-021-02603-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

MFGM components promote gut Bifidobacterium growth in infant and in vitro

Are recent dietary changes observed in the NutriNet-Santé participants healthier and more sustainable?

The female mouse is resistant to mild vitamin B3 deficiency

The effects of long-term moderate exercise and Western-type diet on oxidative/nitrosative stress, serum lipids and cytokines in female Sprague Dawley rats

Tree nut consumption and prevalence of carotid artery plaques: The National Heart, Lung, and Blood Institute Family Heart Study

Micronutrients deficiences in patients after bariatric surgery

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage